Use of horseradish peroxidase for gene-directed enzyme prodrug therapy with paracetamol

British Journal of Cancer

Volumn 90, Issue 9, 2004, Pages 1858-1862

  Tupper, J ^a   Tozer, G M ^a   Dachs, G U ^a  

^a Gray Cancer Institute   (United Kingdom)

Author keywords

Gene therapy; Horseradish peroxidase; Hypoxia; Paracetamol

Indexed keywords

HORSERADISH PEROXIDASE; PARACETAMOL;

ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON TRANSPORT; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; LIVER CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 2642582466     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601780     Document Type: Article

References (27)

1. Adamson GM, Harman AW (1993) Oxidative stress in cultured hepatocytes exposed to acetaminophen. Biochem Pharmacol 45: 2289-2294
2. Aebi S, Lauterburg BH (1992) Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH. Am J Physiol 263: R348-R352
3. Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416
4. Buchsbaum DJ, Raben D, Stackhouse MA, Khazaeli MB, Rogers BE, Rosenfeld ME, Liu T, Curiel DT (1996) Approaches to enhance cancer radiotherapy employing gene transfer methods. Gene Ther 3: 1042-1068
5. Dahlin DC, Miwa GT, Lu AY, Nelson SD (1984) N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 81: 1327-1331
6. Djordjevic SP, Hayward NK, Lavin MF (1986) Effect of N-hydroxyparacetamol on cell cycle progression. Biochem Pharmacol 35: 3511-3516
7. Folkes LK, Wardman P (2001) Oxidative activation of indole-3-acetic acids to cytotoxic species - a potential new role for plant auxins in cancer therapy. Biochem Pharmacol 61: 129-136
8. Greco O, Folkes LK, Wardman P, Tozer GM, Dachs GU (2000) Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid. Cancer Gene Ther 7: 1414-1420
9. Greco O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD (2002a) Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther 9: 1403-1411
10. Greco O, Rossiter S, Kanthou C, Folkes LK, Wardman P, Tozer GM, Dachs GU (2001) Horseradish peroxidase-mediated gene therapy: Choice of prodrugs in oxic and anoxic tumour conditions. Mol Cancer Therap 1: 1-10
11. Greco O, Tozer GM, Dachs GU (2002b) Oxic and anoxic enhancement of radiation-mediated toxicity by horseradish peroxidase/indole-3-acetic acid gene therapy. Int J Radiat Biol 78: 173-181
12. Harman LS, Carver DK, Schreiber J, Mason RP (1986) One- and two-electron oxidation of reduced glutathione by peroxidases. J Biol Chem 261: 1642-1648
13. Manov I, Hirsh M, Iancu TC (2002) Acetaminophen hepatotoxicity and mechanisms of its protection by N-acetylcysteine: a study of Hep3B cells. Exp Toxicol Pathol 53: 489-500
14. McLean AE, Day PA (1975) The effect of diet on the toxicity of paracetamol and the safety of paracetamol - methionine mixtures. Biochem Pharmacol 24: 37-42
15. Miles BJ, Shalev M, Aguilar-Cordova E, Timme TL, Lee HM, Yang G, Adler HL, Kernen K, Pramudji CK, Satoh T, Gdor Y, Ren C, Ayala G, Wheeler TM, Butler EB, Kadmon D, Thompson TC (2001) Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy. Hum Gene Ther 12: 1955-1967
16. Potter DW, Hinson JA (1987) Mechanisms of acetaminophen oxidation to N-acetyl-p-benzoquinone imine by horseradish peroxidase and cytochrome P-450. J Biol Chem 262: 966-973
17. Pumford NR, Halmes NC, Hinson JA (1997) Covalent binding of xenobiotics to specific proteins in the liver. Drug Metab Rev 29: 39-57
18. Reiss M, Brash DE, Munoz-Antonia T, Simon JA, Ziegler A, Vellucci VF, Zhou ZL (1992) Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol Res 4: 349-357
19. Richard AM, Hongslo JK, Boone PF, Holme JA (1991) Structure-activity study of paracetamol analogues: inhibition of replicative DNA synthesis in V79 Chinese hamster cells. Chem Res Toxicol 4: 151-156
20. Sandmair AM, Loimas S, Puranen P, Immonen A, Kossila M, Puranen M, Hurskainen H, Tyynela K, Turunen M, Vanninen R, Lehtolainen P, Paljarvi L, Johansson R, Vapalahti M, Yla-Herttuala S (2000) Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses. Hum Gene Ther 11: 2197-2205
21. Sesardic D, Boobis AR, Murray BP, Murray S, Segura J, de la Torre R, Davies DS (1990) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man. Br J Clin Pharmacol 29: 651-663
22. Springer C, Niculescu-Duvaz D (1996) Gene directed enzyme prodrug therapy (GDEPT): choice of prodrugs. Adv Drug Delivery Reviews 22: 351-364
23. Tarrus E, Cami J, Roberts DJ, Spickett RG, Celdran E, Segura J (1987) Accumulation of caffeine in healthy volunteers treated with furafylline. Br J Clin Pharmacol 23: 9-18
24. Thatcher NJ, Edwards RJ, Lemoine NR, Doehmer J, Davies DS (2000) The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy. Cancer Gene Ther 7: 521-525
25. Timbrell JA (1996) Principles of Biochemical Toxicology. London: Taylor and Francis
26. 4. Biochem Pharmacol 38: 3061-3065
27. van Dillen IJ, Mulder NH, Vaalburg W, de Vries EF, Hospers GA (2002) Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther 2: 307-322